{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:41:51Z","timestamp":1777916511926,"version":"3.51.4"},"reference-count":0,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T00:00:00Z","timestamp":1228435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T00:00:00Z","timestamp":1228435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nephron"],"abstract":"<jats:p>To investigate the role of renal prostaglandin E&lt;sub&gt;2&lt;\/sub&gt; (PGE&lt;sub&gt;2&lt;\/sub&gt;) in renovascular hypertension, urinary PGE&lt;sub&gt;2&lt;\/sub&gt; was measured in rabbits with hypertension produced by left renal artery constriction. In the acute phase of renovascular hypetension (1 week after the constriction), urinary excretions of PGE&lt;sub&gt;2&lt;\/sub&gt; and sodium were significantly increased without correlations with changes in the systemic blood pressure (\u0394BP). In this phase, \u0394BP was directly proportional to plasma renin activity and plasma aldosterone concentration (p &lt; 0.001). In the intermediate phase (5 weeks), \u0394BP lost significant correlations with plasma renin activity and plasma aldosterone concentration and had a inverse correlation with urinary sodium excretion (p &lt; 0.01). In the maintenance phase (10 weeks), \u0394BP showed inverse correlations (p &lt; 0.01) with both PGE&lt;sub&gt;2&lt;\/sub&gt; and sodium excretions, although their excretions decreased to normal levels. In the clipped kidney, only urinary PGE&lt;sub&gt;2&lt;\/sub&gt; excretion in the acute phase was significantly elevated (p &lt; 0.02), and both sodium and PGE&lt;sub&gt;2&lt;\/sub&gt; excretions were significantly decreased (p &lt; 0.01) in the maintenance phase. In the nonclipped kidney, urinary PGE&lt;sub&gt;2&lt;\/sub&gt; and sodium excretions were elevated in the acute and intermediate phases, but decreased to the control levels in the maintenance phase. In this phase, \u0394BP showed inverse correlation (p &lt; 0.01) with both PGE&lt;sub&gt;2&lt;\/sub&gt; and sodium excretions from the nonclipped kidney. The infusion of saralasin, an angiotensin II analogue, dose dependently reduced the blood pressure in the acute phase, but showed no effect in the intermediate and maintenance phases. The present data suggest that the renin-angiotensin system chiefly contributes to the development of hypertension in the acute phase. However, elevated renal PGE&lt;sub&gt;2&lt;\/sub&gt; may also partially act as a defensive factor by promoting urinary sodium excretion. In the maintenance phase, the reduced level of urinary sodium excretion in the nonclipped kidney, which has significant correlation with the reduced level of PGE&lt;sub&gt;2&lt;\/sub&gt;, may play an important role to maintain hypertension instead of the renin-angiotensin system.<\/jats:p>","DOI":"10.1159\/000184219","type":"journal-article","created":{"date-parts":[[2008,12,8]],"date-time":"2008-12-08T08:19:42Z","timestamp":1228724382000},"page":"142-149","source":"Crossref","is-referenced-by-count":5,"title":["Role of Renal Prostaglandin E\n                    <sub>2<\/sub>\n                    in Two-Kidney, One-Clip Renovascular Hypertension in Rabbits"],"prefix":"10.1159","author":[{"given":"Masaki","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehisa","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2008,12,5]]},"container-title":["Nephron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/184219","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000184219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:50:00Z","timestamp":1777657800000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000184219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1159\/000184219","archive":["Portico"],"relation":{},"ISSN":["1660-8151","2235-3186"],"issn-type":[{"value":"1660-8151","type":"print"},{"value":"2235-3186","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,5]]}}}